Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
PPI-383
print preview
bookmark
share with colleague
General Information
Company
Presidio Pharmaceuticals Inc.
Description
Non-nucleoside HCV NS5B polymerase inhibitor
Molecular Target
HCV NS5B polymerase
Mechanism of Action
Latest Stage of Development
Preclinical
Indication
Hepatitis C virus (HCV)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy